Business Description
Regenerx Biopharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US75886X1081
Description
Regenerx Biopharmaceuticals Inc is focused on the discovery and development of novel molecules to accelerate tissue and organ repair. Its operations are confined to one business segment: the development and marketing of product candidates based on Thymosin Beta 4 (Tß4), an amino acid peptide. The company has formulated Tß4 into three distinct product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-137, a topical gel for dermal wounds and reduction of scar tissue; and RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.69 | |||||
| 9-Day RSI | 35.72 | |||||
| 14-Day RSI | 40.85 | |||||
| 6-1 Month Momentum % | 10340 | |||||
| 12-1 Month Momentum % | -98.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -1084.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RGRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Regenerx Biopharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.076 | ||
| EPS (TTM) ($) | -0.903 | ||
| Beta | 4 | ||
| Volatility % | 384.2 | ||
| 14-Day RSI | 40.85 | ||
| 14-Day ATR ($) | 0.001407 | ||
| 20-Day SMA ($) | 0.0014 | ||
| 12-1 Month Momentum % | -98.96 | ||
| 52-Week Range ($) | 0.0002 - 5.18 | ||
| Shares Outstanding (Mil) | 1.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Regenerx Biopharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Regenerx Biopharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Regenerx Biopharmaceuticals Inc Frequently Asked Questions
What is Regenerx Biopharmaceuticals Inc(RGRX)'s stock price today?
The current price of RGRX is $0.00. The 52 week high of RGRX is $5.18 and 52 week low is $0.00.
When is next earnings date of Regenerx Biopharmaceuticals Inc(RGRX)?
The next earnings date of Regenerx Biopharmaceuticals Inc(RGRX) is .
Does Regenerx Biopharmaceuticals Inc(RGRX) pay dividends? If so, how much?
Regenerx Biopharmaceuticals Inc(RGRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers